Mon, Jan 26, 2015, 1:32 PM EST - U.S. Markets close in 2 hrs 28 mins


% | $
Quotes you view appear here for quick access.

Isis Pharmaceuticals, Inc. Message Board

  • dinepat203 dinepat203 Dec 11, 2012 6:20 AM Flag

    ISIS-BIIB Deal - $71M upfront & excess of $1.1Billion from Milestone...Remind U this 3rd major deal 2012

    iogen IDEC (NASDAQ:BIIB), apparently quite impressed with the tech at Isis Pharmaceuticals (NASDAQ:ISIS), has made a third deal with the latter in very short order, paying $30 million upfront and pledging as much as $200 million more in milestones for each of three new programs targeted at neurological diseases and neuromuscular disorders. In all, Biogen has now paid Isis $71 million in upfront payments and and is committed to in excess of $1.1 billion in potential milestones.

    Sentiment: Strong Buy

72.95+1.67(+2.34%)1:31 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.